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Some researchers have reported that lactation is effective in reducing cardiovascular disease risk factors. The 
purpose of this study was to investigate whether lactation may improve intrinsic tolerance against ischemia 
reperfusion (IR) injury. The rats were randomly divided into two groups (n = 8 in each group). In the lactation (Lact) 
group, the surgery was performed on postpartum day 21 (at the end of lactation period) and the results were compared 
with those of virgin female rats (control group). Cardiac IR injury was induced by means of left anterior descending 
coronary artery occlusion for 30 min followed by reperfusion for 120 min. Infarct size was measured using the 
staining agent 2,3,5-triphenyltetrazolium chloride. At the end of the experiment, Mean arterial pressure in the control 
group was significantly lower than that in the Lact group. Myocardial infarct size was significantly reduced in the 
Lact group (23 ± 3% vs. 45 ± 8%, p < 0.05 in the control group). Lactation reduced the extent of myocardial injury 
induced by ischemia and reperfusion. So, lactation may increase cardiac tolerance to ischemic injury.
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Recent researches have indicated that lactation has impacts on maternal health through 
effects on hypothalamic, autonomic, and cardiovascular functioning both during the 
breastfeeding period and after weaning. Lactation is associated with increased parasympathetic 
and decreased sympathetic activity (30), less atherogenic lipid profile and improved fasting 
glucose (18), decreased risk of developing hypertension (39), the metabolic syndrome (19), 
and cardiovascular disease. One may speculate that a complex hormonal cascade triggered 
by lactation can influence a number of different factors like blood pressure regulation, glucose 
homeostasis and insulin secretion, lipid homeostasis, and inflammatory processes (12).
The tissue damage caused by restoration of blood flow after a period of ischemia is 
known as ischemia reperfusion (IR) injury. The results from therapeutic targeting of the 
individual components of lethal myocardial IR injury, including oxidative stress, calcium 
overload, pH correction, and inflammation have been disappointing (21). So for several 
decades, there has been a concerted effort in cardiology to identify interventions to increase 
the heart resistance to infarction. In 1986, Murry et al. first introduced the concept of 
“conditioning” the myocardium to protect it against IR injury (32). Exposure to brief periods 
of ischemia (called ischemic preconditioning [IPC]), prior to prolonged ischemia, has been 
recognized as a powerful endogenous form of cardioprotection (21). However, this 
intervention was both invasive and impractical to apply, and non-invasive approaches for 
protecting the heart were sought such as exposure to a brief limb ischemia (remote IPC) (25), 
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pharmacological agents, hyperoxic environment, exercise and so on. In experimental IR 
injury models, the protective effect of a wide range of hormones, including oxytocin (34), 
prolactin (26), estrogen (4), thyroid hormone (33), and endogenous substances, including NO 
(23), and heat shock proteins (14) including heme oxygenase-1 (24) has been shown. Due to 
substantial changes in the factors involved in the regulation of cardiovascular function during 
lactation, the purpose of the present study was to explore whether lactation may protect the 
heart against ischemia reperfusion (IR) injury in an in vivo rat model. 
Materials and Methods
Animals
Female Wistar rats (weighing 200–250 g) were housed under standard conditions with free 
access to food and water. The investigation was approved by the animal and human ethics 
committee of Islamic Azad University (51601901119002).
Experimental protocols 
The rats were randomly divided into two groups (n = 8 in each group). In the Lact group, each 
female was paired with a male until they looked visibly pregnant. On postpartum day 21 (at 
the end of lactation period), the rats underwent surgery. In the control group, each female was 
paired with another female. During this time (almost 42–45 days), virgin control rats were 
maintained in separate cages and then they underwent surgery. The rat estrous cycle is 
typically 4–5 days in length. Pregnancy lasts about 21–22 days. The pups are typically 
weaned by 21 days of age. The serum estradiol level fluctuations during various estrous cycle 
stages of rats do not influence cardiac IR injury and are not correlated with infarct size or 
arrhythmia. Because endogenous changes in reproductive hormones do not appear to be a 
confounding variable in IR studies (15), the serum estradiol level and estrous cycle stages of 
rats was not assessed.
Surgical procedure
The procedure used in the present study was described in our previous experiments (37). 
In brief, the animals were anesthetized with sodium pentobarbital (30 mg.kg–1) and ketamin 
(50 mg.kg–1) i.p. Rectal temperature was continuously monitored and maintained at 37 ± 
0.5 °C. Following tracheotomy, the rats were ventilated with room air enriched with oxygen 
at a rate of 70 to 80 per min and tidal volume of 1 ml·kg–1 to maintain blood PO2, PCO2, and 
pH in the normal physiological range. A standard limb lead II electrocardiogram (ECG) was 
monitored and recorded throughout the experiment. Catheters were inserted into the left 
carotid artery and tail vein (Angiocat 23; Suppa, Tehran, Iran) for monitoring blood pressure 
and infusion of Evans blue solution, respectively. A left thoracotomy was performed and the 
pericardium was opened to expose the heart. A 6-0 silk suture was passed around the left 
anterior descending coronary artery (LAD) and its ends were threaded through a small plastic 
tube to form a snare. Following a stabilization period of 20 min, the artery was occluded for 
30 min by clamping the snare against the surface of the heart. Ischemia was confirmed by 
regional cyanosis and ST elevation in the ECG. Reperfusion was established by releasing the 
snare for 120 min.
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Determination of infarct size and area at risk
At the end of reperfusion, the LAD was re-occluded and 1 ml Evans Blue dye %1 (Sigma, 
St. Louis, MO) was injected into the tail vein to identify the area at risk (AAR). The heart 
was excised, rinsed of excess blue dye, trimmed of the atria and right ventricle, put in a 
matrix, wrapped in plastic foil and frozen at –20 °C (2 h). The left ventricle (LV) was cut into 
transverse slices of 2 mm thickness from the apex to the base. Tissue samples were then 
incubated in triphenyltetrazolium chloride 1% [TTC (Sigma)] solution in isotonic phosphated 
buffer, pH = 7.4, for 20 min at 37 °C, and subsequently fixed in 10% formalin for 1 h. Viable 
tissue was stained red by TTC, whereas infarcted tissue remained unstained (white). An 
image was obtained (canoscan LID 25) from both sides of each slice and all calculations from 
one heart (using Image Tool Software) were averaged into one value for statistical analysis. 
The total area at risk was expressed as a percentage of the left ventricles (AAR/LV). Infarct 
size (IS) was expressed as a percentage of the AAR (IS/AAR).
Assessment of ventricular arrhythmias
Ischemia-induced ventricular arrhythmias were determined in accordance with the Lambeth 
conventions (41): premature ventricular complexes (PVCs as a discrete and identifiable 
premature QRS complex (premature with respect to the P wave), ventricular tachycardia 
(VT) as a run of four or more PVC at a rate faster than the resting sinus rate and ventricular 
fibrillation (VF) as a signal for which individual QRS deflection can no longer be distinguished 
from one another. Complex forms (bigeminy and salvos) were added to PVCs count and not 
analyzed separately.
Statistical analysis 
Statistical analysis was carried out using SPSS software (version 16). Data are expressed as 
mean ± SEM or as percent. Student’s t-test or Fisher exact test was used to analyze the data. 
Values of P < 0.05 were considered as significant.
Results
Hemodynamic parameters
Table I summarizes the hemodynamic data. There were no significant differences at baseline 
values for heart rate (HR) and mean arterial blood pressure (MAP) between the groups. 
Ischemia caused a marked decrease in blood pressure. At the end of the experiment, MAP in 
the control group was significantly lower than that in the Lact group.
 
Table I. Hemodynamics parameters in experimental groups
Groups Baseline Ischemia Reperfusion
HR MBP HR MBP HR MBP
Control 331 ± 23 123 ± 13 341 ± 23   101 ± 22** 326 ± 16      91 ± 14** #
Lact 321 ± 16 124 ± 13 341 ± 43 112 ± 15* 335 ± 40 111 ± 14*
Control = Virgin female rats, Lact = Female rats that completed lactation period after parturition.
* P < 0.05, ** P < 0.01 compared with the baseline values within the same group
# P < 0.05 compared with other group 
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Myocardial infarct size
The effect of lactation on myocardial infarct size is shown in Fig 1. The size of AAR did 
not differ between the two groups, indicating equal position of LAD occlusion. Myocardial 
infarct size was significantly reduced in the Lact group (23 ± 3% vs. 45 ± 8%, p < 0.05). 
Fig. 1. Infarct size (IS) and area at risk (AAR) following 30-min ischemia and 120-min reperfusion in rats.  
LV = left ventricle; * P < 0.05 compared with the other group.  
Control = Virgin female rats, Lact = Female rats that completed lactation period after parturition
Ischemia-induced arrhythmias
The results of lactation on ischemia-induced arrhythmia are shown in Table II. During 30-
min ischemia, the numbers of PVC, episodes of VT and duration of VT in the control group 
were 258 ± 35, 31 ± 6 and 31 ± 6 sec, respectively. The rate of these arrhythmias in the Lact 
group was reduced, but it was not significant. VF occurred nearly in 75% of rats in both 
groups. A rat (in the control group) died due to irreversible VF during ischemia. Mortality 
rate did not differ in this relatively small sample. There were no considerable reperfusion 
induced arrhythmias in the present work.
Table II. Incidence of ventricular arrhythmias during 30 min of ischemia in the Control and Lact groups
PVC (n) VT (n) VT duration (sec) VF (%)
Control group 258 ± 35 31 ± 6 31 ± 6 77.8%
Lact group 236 ± 30 28 ± 5 23 ± 6 75%
The numbers of premature ventricular complexes (PVC), the episodes of ventricular tachycardia (VT),  
and VT duration (as means ± SEM) and the incidence of ventricular fibrillation (VF) (as percent) are shown.  
Control = Virgin female rats, Lact = Female rats that completed lactation period after parturition
Discussion
The main findings of this study were: 1) A significant decrease in infarct size (IS) following 
30-min of ischemia and 120 min of reperfusion was observed in the Lact group, 2) At the end 
of the lactation period, no significant changes were observed in hemodynamic parameters 
compared to the control group, 3) Ischemia induced arrhythmias were reduced in the Lact 
group, but no statistical significance was reached.
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The incidence of ventricular arrhythmia, infarct size, and mortality positively correlated 
with the size of the ischemic area in animal models (6, 10). In this study, as in previous 
studies (8), VF occurred as a self-limited arrhythmia in 75% of rats in both groups. However, 
a rat (in the control group) died due to irreversible VF during ischemia. 
The concept of therapeutic infarct size limitation was first promoted by Maroka 
et al. (29). Myocardial salvage is a potential strong endpoint for success in acute reperfused 
myocardial infarction (20). Our study indicated that the lactation can provide cardiac 
protection against IR injury by decreasing IS. Consistent with our findings, Faltová et al. 
showed that in lactating mothers the extent of isoprenaline-induced heart lesions and 
mortality were significantly decreased; moreover, the resistance of the right ventricle to 
anoxia was higher than that of virgin females (13). 
The effect of lactation in IR injury model has not been studied so far. To our knowledge, 
this is the first animal experimental demonstration showing that lactation can mimic 
preconditioning. There were no significant changes in basal hemodynamic values on 
postpartum day 21. So, the protective effect of lactation on the myocardium is not related to 
alterations in hemodynamic parameters. It is a new benefit of breastfeeding in encouraging 
mothers to choose nursing.
Some clinical studies have established that there is a dose-dependent relationship 
between lactation and reduced risk of coronary heart disease (12, 36). Although the 
mechanisms are still debated, it has been hypothesized that lactation may influence several 
pituitary hormones and induce even long-term changes in the hypothalamic-pituitary axis 
(12). After parturition, large quantities of prolactin and oxytocin (OT) are released from the 
pituitary gland into the circulation in response to a suckling stimulus. Principal site of 
prolactin is the mammary gland. Few studies have investigated the potential role of prolactin 
in the increased risk of cardiovascular events, e.g. essential hypertension, the heart failure 
that accompanies Peripartum cardiomyopathy, and arrhythmias (7, 22). On the other hand, 
the positive influence of prolactin on the cardiovascular system was shown. Results of a 
study showed that administration of supraphysiological doses of prolactin isoforms could 
protect against sudden cardiac death as well as severe arrhythmias episodes during reperfusion 
(26). In general, experimental data and clinical observations remain contradictory.
OT synthesis and receptors are found in cardiac and vascular tissue (17). It has been 
reported that lactation alters maternal cardiovascular function, possibly through the actions 
of OT (31). Favourable effects of lactation on blood pressure have been attributed to OT 
(28). In animal models, the administration of OT leads to decreased blood pressure (35) and 
a reduction of myocardial infarct size in the rat (34). In addition, blockade of OT receptors by 
atosiban abrogates the cardioprotective effects of IPC (1). 
The cardioprotective effects of glucocorticoids and adrenocorticotropin in IR injury 
have been experimentally demonstrated in animals (5, 40) and humans (16). Although a 
decline in the serum cortisol and adrenocorticotropin concentrations in the breast feeding 
women was found (2), there is a positive association between duration of lactation and 
cortisol levels in postmenopausal women (27), that means that both increased cortisol levels 
and increased duration of breast-feeding have protective roles in the cardiovascular system.
The release of OT and prolactin during suckling is associated with the vagus nerve 
activity (11). The results of previous studies have shown that vagus nerve stimulation (VNS) 
offers protection against ischemic brain (3) and myocardial (38) injury. The researchers 
found that cardioprotective effects of VNS including reduced infarct size and decreased 
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ventricular fibrillation episodes were abolished by muscarinic blockade (38). On the other 
hand, the protective signal of remote IPC reaches the heart through the vagus nerve and 
activation of muscarinic receptors (9). 
Together these data suggest that lactation by a wide range of hormones and different 
pathways creates protective alterations in the cardiovascular function that have not yet been 
revealed. So, the mechanisms causing this protection remain to be explored. Also, it is 
necessary to reproduce this experiment to identify whether lactation also creates protection 
for other tissues against IR injury. The duration of the protective effect of lactation after 
weaning should also be determined. Future research is needed for the comparison of maternal 
females with and without breastfeeding.
In summary, lactation reduced the extent of myocardial injury induced by ischemia and 
reperfusion. So, there is evidence that lactation may increase cardiac tolerance to ischemic 
injury and is considered to be as a preconditioning stimulus in the lactating mothers.
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